PARIS AI Poly
Polypharmacy risk intelligenceGives the clinician a single actionable risk tier, with a defensible recommendation, for patients on several medicines. Built on regulatory adverse-event evidence and delivered across platforms.
Innovation portfolio
Fourteen innovations across four domains, priced and configured to be within reach of NHS, government and multilateral buyers.
Clinical AI and Health Intelligence
Clinical decision-making runs on threshold alarms that report a crisis once it has arrived, and risk scores with no time dimension. These innovations bring foresight to acute, primary and post-acute care.
Delivers: Software as a medical device, multi-platform clinical applications, wearables-based monitoring and NHS-grade decision support.
The PARIS AI suite
Explore PARIS AI
From detection to prediction: giving clinicians time to act
The Polypharmacy Advanced Risk Intelligence System, in three components: medication risk, acute events and recovery.
- Before harm
- The acute event
PARIS AI AEP
Acute Events PreventionTells the care team how long before a patient crosses a clinical threshold, and with what confidence, across fourteen clinical specialties. The first in product form is PARIS AI Sepsis AEP.
See the fourteen domains - Recovery
PARIS-Ai Rehab
Rehabilitation trajectory monitoringTracks recovery across eleven rehabilitation pathways and five functional domains, predicts recovery trajectories and identifies setbacks before they occur, so that intervention can be well timed.
Economic and Fiscal Intelligence
Economic and fiscal tooling for finance ministries, central banks and development institutions is underserved at the price point they can reach, and lacks a formal measure of how an indicator has structurally evolved.
Delivers: Fiscal, macroeconomic and agricultural-trade intelligence for ministries, central banks and development institutions.
MERD
Agricultural trade intelligenceTrade-policy analysis on the full FAOSTAT dataset that measures how a product's position in an economy has evolved, refreshed monthly against FAOSTAT and UN COMTRADE.
Also delivered as the MERD analysis app series for iOS: agricultural analytics from inputs to trade and food security, working offline.
In development
Further innovations in clinical AI, drug safety, financial forensics and economic intelligence are in development, with details available on request.
- Clinical AI
- Drug safety
- Financial forensics
- Economic intelligence
Expert services
Consultancy and development
Data science, statistical modelling, health technology validation, and iOS and macOS development, from proof of concept to deployed system.
Speak with our expertsWorking with the portfolio
Clinical partners, regulators, finance ministries and development institutions each engage with a different part of the portfolio. Tell us which, and we will send the relevant material under NDA.